RD

Rahul Dilip Chitlange

Active Director Director DIN 10791854
DIN 10791854 First appointment Sep 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rahul Dilip Chitlange

Data last updated:

Rahul Dilip Chitlange is a Director at Salasar Biotech Private Limited (since 2024).

DIN 10791854
Primary Designation Director
First Appointment 28 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Salasar Biotech Private Limited U32909PN2024PTC234590
Director28 Sep 20242024Active

Board colleagues of Rahul Dilip Chitlange

Directorship timeline

Open interactive timeline →
Salasar Biotech Private Limited
Premium access

Shareholding and investment profile for Rahul Dilip Chitlange

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Dilip Chitlange

Rahul Dilip Chitlange currently holds 1 directorship: Salasar Biotech Private Limited (Director, since 28 Sep 2024).

Rahul Dilip Chitlange was first appointed on 28 Sep 2024 as Director at Salasar Biotech Private Limited.

The current boards of Rahul Dilip Chitlange's companies include Ankush Raju Sawana (Salasar Biotech Private Limited), Sarvesh Gopaldas Laddha (Salasar Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available